FLUKE BRADLEY J 4

4 · CIRRUS LOGIC, INC. · Filed Feb 6, 2020

Form 4

Period: 2020-02-04

Vice President and GM

Transactions

Exercise/Conversion
Common Stock
2020-02-04$55.72/sh+3,000$167,160→ 6,120 total
Exercise/Conversion
Common Stock
2020-02-04$54.65/sh+3,000$163,950→ 6,120 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-02-04−2,000→ 1,000 total
Exercise: $31.25Exp: 2025-11-04→ Common Stock (2,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-02-04−3,000→ 7,088 total
Exercise: $41.49Exp: 2028-11-07→ Common Stock (3,000 underlying)
Exercise/Conversion
Common Stock
2020-02-04$31.25/sh+2,000$62,500→ 5,120 total
Sale
Common Stock
2020-02-04$78.80/sh−2,000$157,593→ 3,120 total
Exercise/Conversion
Common Stock
2020-02-04$41.49/sh+3,000$124,470→ 6,120 total
Sale
Common Stock
2020-02-04$78.80/sh−3,000$236,390→ 3,120 total
Sale
Common Stock
2020-02-04$78.80/sh−3,000$236,390→ 3,120 total
Sale
Common Stock
2020-02-04$78.80/sh−3,000$236,390→ 3,120 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-02-04−3,000→ 5,767 total
Exercise: $54.65Exp: 2026-11-02→ Common Stock (3,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-02-04−3,000→ 7,706 total
Exercise: $55.72Exp: 2027-11-01→ Common Stock (3,000 underlying)

Footnotes (5)

[F1]The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.30 - $79.40. The reporting person will provide full information regarding the number of shares bought as each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request.
[F2]Only vested shares can be exercised under this option. 25% of the shares vested on 11/4/16; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 11/4/19.
[F3]Only vested shares can be exercised under this option. 25% of the shares vested on 11/7/19; the remaining shares will vest monthly over the following 36 months so that the option will be fully vested and exercisable on 11/7/22.
[F4]Only vested shares can be exercised under this option. 25% of the shares vested on 11/2/17; the remaining shares will vest monthly over the following 36 months so that the option will be fully vested and exercisable on 11/2/20.
[F5]Only vested shares can be exercised under this option. 25% of the shares vested on 11/1/18; the remaining shares will vest monthly over the following 36 months so that the option will be fully vested and exercisable on 11/1/21.

Documents

1 file